A recent study published in the journal Psychiatry Research shows no link between prolonged recreational cannabis use and psychosis, even in a cohort of adolescents deemed to be at high risk of developing the disorder. Scientists affiliated with Hofstra University in New York and with Stanford [...]
A new report explores the progression of cannabis research over the last decade, as well as the barriers holding back further developments in the pharmaceutical space. We take a look at some of the key takeaways. The report, published today by Prohibition Partners and Cannabiscientia, gives [...]
Cannabinoids may be beneficial for managing symptoms in children with cancer, a new review finds, but more extensive research is needed. A recent analysis of existing research suggests that while cannabinoids are increasingly being used to manage symptoms in childhood cancer, there is a lack of [...]
Massively promising news for the cannabis industry today that many are calling historic: the Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA), recommending that cannabis be rescheduled from Schedule I to Schedule III. The news was originally [...]
In the wake of the 2018 Farm Bill, the horizons of hemp-derived cannabis products expanded, offering nearly limitless opportunities for businesses and brands in the CBD industry to expand what they could offer to their customers. However, threading the path to prosperity within this new regime [...]
Representatives of the UK CBD industry are urging the Home Office to protect the sector, and reassure millions of consumers, with greater clarity and stricter regulation. A new campaign, led by the Association for the Cannabinoid Industry (ACI), is calling on the Home Office to implement [...]
In a new study, cannabis was not associated with increased rates of psychosis or other adverse health outcomes among adolescents classed as ‘high risk’ for the disorder. Researchers at Hofstra University in New York and Stanford University in California, assessed the relationship between cannabis use and [...]
Here we are again, crossing our fingers, hoping that the Senate will approve the passage of the Secure and Fair Enforcement Banking Act (SAFE Banking Act). This Act would provide banks with regulatory protections, allowing them to offer critical financial services to cannabis businesses without risking [...]
In any industry that is labeled as the “Wild West,” the ability to discern your target market, collect accurate data and strategically drive success has become paramount. With factors such as invisible shoppers, anyone who is a customer of a brand or dispensary and does not [...]
This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU [...]
We bring you the news you might have missed from the week just gone. The top lines this week: The Swiss city of Zürich launches its adult-use cannabis pilot, Israel’s major reforms aim to make medical cannabis a ‘first line treatment’, and a global study will [...]
Via Business of Cannabis Israel could soon see a dramatic increase in the number of medical cannabis patients as the government publishes proposals for sweeping reforms aimed at streamlining access. On Monday 7 August, The Health Ministry published its highly anticipated proposals for medical cannabis reform in [...]
In his final instalment, consultant psychiatrist and cannabis clinician Dr Tahzid Ahsan, explores the potential of cannabis in managing symptoms of ADHD and autism. Around three in 10 autistic adults and around 28% of autistic children also have ADHD. The likelihood of someone presenting with both [...]
Cannabis scientist Lex Pelger brings you the latest cannabinoid research with new studies exploring CBD for ageing and hair growth, plus fibromyalgia, Alzheimer’s, binge eating disorder and more. Lex Pelger is a biochemist specialising in cannabinoids and psychedelics. Here we share an extract from his newsletter, [...]
The Swiss city of Zurich has marked a significant milestone with the official launch of its cannabis pilot trial ‘ZüriCan’ this week. The trials represent a major development in the legalisation and regulation of cannabis in Switzerland. The second pilot, which began on Tuesday 22 August, [...]
A new study highlights the myriad of benefits medical cannabis can have on patients’ quality of life, from reducing symptoms to boosting energy levels and job performance. Researchers in Greece studied a group of patients receiving medical cannabis treatment to try to understand how it impacted [...]
After the US, the UK saw the second highest number of clinical trials carried out on cannabinoids in the last decade, according to a new report. The upcoming report, due to be published this month by Prohibition Partners and Cannabiscientia, explores the progression of cannabis research [...]
Researchers in Australia will explore whether treatment with medicinal cannabis can ease the economic impact of chronic health conditions. Australians living with one of 200 chronic conditions may now be eligible to participate in what is expected to become the world’s largest study into the impact [...]
A dad-of-two, serving five years for supplying cannabis to help severely ill patients, has been moved to an open prison as his family prepare to launch an appeal against his sentence. The family of Patrick Moore, who was sentenced to five years for the cultivation and [...]
Founder and CEO Chase Eastman officially launched Rootwurks in January 2022. But the journey began years earlier, and passed through industries including food safety training and digital media and television. Rootwurks at its core is a training platform. The cannabis industry deals with an incredibly complex [...]
Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry – late last year, vendors turned off services to their cashless ATMs. These abrupt [...]
This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European cannabis [...]
We bring you the news you might have missed from the week just gone. The top lines this week: The German Cabinet approved a bill to implement the first phase of adult-use cannabis legalisation, while Malta moves to issue its first cannabis association licences. In the [...]
A new study has found that states which have legalised medical cannabis have seen a drop in the average cost of individual healthcare premiums. Researchers from Bowling Green State University in Ohio and Illinois State University looked at the impact of state-specific medical cannabis legalisation laws [...]
Via Business of Cannabis The head of Malta’s cannabis regulatory body has confirmed reports that the country’s first two cannabis associations have been granted licences, ‘in-principle’. Two years after Malta first moved to allow the consumption and cultivation of cannabis for adult-use, the Authority for the Responsible [...]
NHS Scotland is funding a six-figure clinical trial to explore the effects of CBD on pelvic pain related to endometriosis. The Chief Scientist Office, part of the Scottish Government Health Directorate responsible for funding research in NHS Scotland, will provide £300,000 for the trial, Ananda Developments, [...]
The German Cabinet has passed a bill for the first phase of adult-use cannabis reform, whilst demonstrating its commitment to harm-reduction and youth protection. On Wednesday, members of the German cabinet passed the draft of a bill which will see the country take its first steps [...]
Between 2020 and 2021, cannabis vape cartridges saw 25% year-over-year growth and all-in-one vapes grew a whopping 64% as a category during the same time period. Two years later, the vape space shows no signs of slowing down. There are more strain and extraction style options [...]
The vaping technology market is a constantly evolving landscape, driven by the changing needs and preferences of consumers. Staying relevant in this competitive market requires companies to deliver exceptional vape experiences. Airo Brands has risen to the challenge since its inception, offering a diverse product portfolio [...]
A new study by researchers in the US is the first to shed light on how HHC binds to receptors in the body – and proposes a safer, more consistent way to produce them. The new paper takes a closer look at hexahydrocannabinol, or HHC, an [...]
New research suggests a growing awareness and interest in medical cannabis as an alternative to opioid medications among GPs practising in the UK. Almost two-fifths (37%) of GPs believe that medical cannabis has the potential to reduce patient dependency on other medications and improve quality of [...]
As CBD becomes increasingly popular among athletes, Scott Mazza, COO and co-founder of Vitality CBD, shares some tips for using it safely in sport. CBD is taking the fitness world by storm. With evidence showing the compound helps to reduce inflammation, improve recovery and promote focus [...]
The cannabis industry isn’t a level playing field. It’s disheartening to say. But as someone who has been building a soon-to-open dispensary for the last three years, I’ve experienced this lack of equity firsthand. It starts with the industry’s foundation. We’re in an era where anyone [...]
Ahead of National CBD day on Saturday 8 August, we explore some of the key differences between CBD wellness products and prescribed medical cannabis. While legalisation of recreational cannabis is far off in this country, medical cannabis has been legal since 2018 – yet over half [...]
Following another recent disappointment for Spanish patients, Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals explores the barriers preventing the regulation of medical cannabis in the country. What is wrong with medical cannabis access in Spain? In short: Politics! Spain has long been the most head-scratching [...]
While pre-rolls are finally getting their moment, posting notable growth across virtually every market, much of that growth has been powered by the infused pre-roll subcategory. In Michigan, for example, infused pre-rolls now make up over 40% of the category, and 9 of the top 10 [...]
Vaping is a popular way to consume CBD, but how safe is it? We take a look at the potential benefits, effects and risks. While tinctures and oils have conventionally been the most common way of getting a dose of CBD’s potential health and wellness benefits, [...]
Althea’s cannabis-based oil has been given the green light from Ireland’s regulators to be prescribed free of charge through the Medical Cannabis Access Programme (MCAP). The global manufacturer of cannabis-based medicines has successfully secured approval from The Republic of Ireland’s Primary Care Reimbursement Service for its [...]
Via Business of Cannabis A ‘landmark’ Court of Appeal ruling in the UK has set a new legal precedent for businesses in the UK importing and selling CBD or low-THC hemp flower. Crucially, the Court of Appeal has made it clear that it does not consider hemp flower [...]
Tahir Johnson is the founder and CEO of Simply Pure Trenton, the first black-owned social equity dispensary to receive a license in New Jersey. He’s a well-known cannabis advocate who’s held leadership roles at the Marijuana Policy Project, the National Cannabis Industry Association (NCIA) and the [...]
Researchers have found little evidence of a link between high potency cannabis and an increased risk of psychosis and other mental health symptoms. A team of researchers at the University of Bath have explored the association between cannabis potency and the likelihood of developing cannabis dependence [...]
In a new study of the CBD content in products on sale in the UK, the majority were found to contain significantly lower concentrations than what was advertised. Researchers analysed the actual concentrations of CBD in a sample of products on sale in the UK and [...]
We’ve rounded up some of the most recent research in the field of cannabis medicine, including its potential therapeutic effects in a number of debilitating chronic conditions. While more studies are needed, new findings indicate potential for cannabis as a tool to manage symptoms of amyotrophic [...]
Researchers from the University of Bath used donated cannabis to produce accurate results in a study conducted to test the hypothesis that users of high-strength cannabis would experience more anxiety, depression and psychosis-like symptoms than users of lower-strength cannabis. Previous studies have found associations between the [...]
A clinical trial investigating the efficacy of cannabis-based medicines in up to 5,000 patients with chronic pain has been given the green light from UK regulators. Celadon Pharmaceuticals, a licensed producer of cannabis-based medicines in the UK and is private pain clinic, LVL Health, have received [...]
Universities across the country are working in all areas of research and development to advance cannabis cultivation, medicine, drug delivery and technology. But these innovations are collecting dust because the universities are not in the business of commercializing products in the marketplace. In 1980, the federal [...]
The roll-out of cannabis reform in Malta is said to have brought a ‘significant transformation’ in the health and wellbeing of consumers, despite some concerns from opposition groups that cannabis is becoming ‘normalised’. In December 2021, Malta became the first country in Europe to give the [...]
The problems facing the cannabis industry arising from its ongoing status as a federally illegal enterprise are numerous and well documented: 280E tax burdens, limited access to banking, exclusion from capital markets, uneven access to federal intellectual property right protections and the inability to access the [...]
Via Business of Cannabis Albania has become the latest European country to officially legalise the ‘cultivation and processing of the cannabis plant and the production of its by-products for medical and industrial purposes’. The vote, which took place on Friday July 21, has already been met [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
